Skip to content
Get alerts
GovInfoNow
Stop using now Drug recall · FDA · Published February 8, 2022

Your Favorite Shop: Red Pill Extra Strength Capsules Unapproved Drug Risk

Your Favorite Shop recalls Red Pill Extra Strength 800mg capsules (ASIN B0847BSQQ5) due to undeclared tadalafil, an unapproved drug ingredient. Consumers should stop using immediately.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0630-2022DrugYour Favorite Shop ›
Take action

Contact the company

Recalling firmYour Favorite Shop14 Imperial Pl · Jackson, NJ 08527-5173
✎ GovInfoNow plain-language explainer

Your Favorite Shop is recalling Red Pill Extra Strength capsules (800mg, 10-count) because they contain undeclared tadalafil, an ingredient approved for male sexual enhancement. This makes the product an unapproved drug that could pose health risks. Read more at govinfonow.com/recall/35230-your-favorite-shop-red-pill-extra-strength-capsules-unapproved-drug.

Source Summary by GovInfoNow · govinfonow.com/recall/35230-your-favorite-shop-red-pill-extra-strength-capsules-unapproved-drug · Updated August 18, 2026 · FDA enforcement record: FDA #D-0630-2022

Cite this page

“Your Favorite Shop: Red Pill Extra Strength Capsules Unapproved Drug Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35230-your-favorite-shop-red-pill-extra-strength-capsules-unapproved-drug. Based on FDA recall #D-0630-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0630-2022%22&limit=1).

The Food and Drug Administration announced on Feb. 8, 2022, that Your Favorite Shop voluntarily recalled THE RED PILL, EXTRA STRENGTH capsules due to undeclared tadalafil. The agency classified the Class I recall as a market withdrawal for products distributed nationwide via Amazon Marketplace.

How to tell if you have it

  • Brand: Your Favorite Shop
  • Product: THE RED PILL, EXTRA STRENGTH capsules, 800 mg
  • Packaging: 10-count blisters in a carton
  • ASIN: B0847BSQQ5
  • Barcode: X002G5GMJ1
  • Lot #: 26436989
  • Expiration date: 10/30/2023
  • Units affected: 12,500 cartons

The hazard

The product was found to contain undeclared tadalafil, an ingredient found in FDA-approved products for the treatment of male sexual enhancement. This makes THE RED PILL an unapproved drug marketed without an approved New Drug Application or Abbreviated New Drug Application.

Context

GovInfoNow's records show other recent recalls of similar products include StuffbyNainax MR 7 SUPER 700000 Capsules (2025-12-15) and Buy-Herbal Kian Pee Wan Capsules Recall (2026-03-21). Additional recent recalls in this category include TRP Gentle Eyes Lubricant Eye Drops Recall (2026-08-20).

How to tell if you have this one

Check for the product name 'Red Pill Extra Strength capsules, 800 mg, 10-count blisters in a carton' with ASIN B0847BSQQ5. The lot number is 26436989 and expires 10/30/2023.

  • Brand
    Your Favorite Shop
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately stop using the recalled Red Pill Extra Strength capsules as they contain undeclared tadalafil, an unapproved drug ingredient.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Product was distributed nationwide in the USA via the internet through Amazon Marketplace.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 49 days after the firm started it.

1. Firm started the recall: Feb 8, 202212. FDA classified it Class I: Feb 23, 202223. Published in FDA’s Enforcement Report: Feb 23, 202234. FDA terminated the recall: Mar 29, 202242022
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Gadget Island DYNAMITE SUPER Capsules: Unapproved Drug Risk
Gadget IslandStuffbyNainax MR 7 SUPER 700000 Capsules: FDA Finds Undeclared Sildenafil and Tadalafil
StuffbyNainaxNoah's Wholesale THE ROCK Capsules: Unapproved Sildenafil Risk
Noah's Wholesale LLCArize Herbal Supplement Recall: Unapproved Drug Risk
Today The WorldAlpha Male+ Chew Strips Recall: Unapproved Tadalafil Risk
Alpha-Tek

Latest drug recalls

American Health Packaging recalls Metoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only, Distributed by: American Health Packaging, Columbus,
American Health Packaging · October 6, 2026Teva Pharmaceuticals USA, Inc recalls Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals,
Teva Pharmaceuticals · September 29, 2026Preferred Pharmaceuticals, Inc. recalls Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A.,
Preferred Pharmaceuticals · September 28, 2026SUN PHARMACEUTICAL INDUSTRIES INC recalls Tretinoin Cream USP, 0.05%, 45 g tube, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Taro
Northstar Rx · September 25, 2026Apothecary Pharma LLC recalls Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary,
Apothecary Pharma · September 24, 2026Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0630-2022 (February 8, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0630-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA